David M. Peereboom

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma

Patrick Y. Wen, David A. Reardon, Terri S. Armstrong et al. · Clinical Cancer Research · 2019 · 272 citations · Full text

Medicine, Immunology, Oncology +17

Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

Farshad Nassiri, Vikas Patil, Leeor Yefet et al. · Nature Medicine · 2023 · 270 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional Experience

Lilyana Angelov, Nancy D. Doolittle, Dale F. Kraemer et al. · Journal of Clinical Oncology · 2009 · 234 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme

David M. Peereboom, Dale R. Shepard, Manmeet S. Ahluwalia et al. · Journal of Neuro-Oncology · 2009 · 199 citations

Medicine, Oncology, Pharmacology +14

Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study

Aki Morikawa, David M. Peereboom, Helen R. Thorsheim et al. · Neuro-Oncology · 2014 · 172 citations · Full text

Medicine, Oncology, Pharmacology +17